Opioid combination for cancer pain [1]

British Journal of Cancer

Volumn 90, Issue 10, 2004, Pages 2049-

  Mercadante, S ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE; OPIATE RECEPTOR; OXYCODONE; NARCOTIC ANALGESIC AGENT;

ANALGESIC ACTIVITY; CANCER PAIN; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; VOMITING; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG RESISTANCE; NEOPLASM; NOTE; PAIN;

ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMANS; NEOPLASMS; PAIN;

EID: 2942544474     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601806     Document Type: Letter

References (3)

1. He L, Fong J, von Zastrow M, Whistler JL (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108: 271-282
2. Lauretti GR, Oliveira GM, Pereira NL (2003) Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients. Br J Cancer 89: 2027-2030
3. Ross FB, Wallis SC, Smith MT (2000) Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced SNC side-effects in rats. Pain 84: 421-428